发明名称 |
USE OF NUCLEIC ACID MOLECULE, PHARMACEUTICAL COMPOSITION CONTAINING IT AND A NUCLEIC ACID MOLECULE |
摘要 |
<p>The invention relates to the use of an Egr-1 transcription factor polypeptide or a biologically active fragment thereof, and to nucleic acid molecules encoding such polypeptides, in the manufacture of a medicament for the treatment of wounds in a mammal, including human. In addition, it relates to a sequence that is believed to include important regions involved in the transcription of the transcription factor Egr-1 in humans and in the regulation thereof. This sequence can be used to design appropriate nucleic acid molecules and vectors that can be used in the treatment of wounds, as well as in other treatment.</p> |
申请公布号 |
SK18322000(A3) |
申请公布日期 |
2001.11.06 |
申请号 |
SK20000001832 |
申请日期 |
1999.06.02 |
申请人 |
GLAXO GROUP LIMITED |
发明人 |
BRADDOCK MARTIN;CAMPBELL CALLUM JEFFREY;SCHWACHTGEN JEAN-LUC |
分类号 |
C12N15/09;A61K;A61K35/76;A61K38/00;A61K38/17;A61K48/00;A61P17/02;A61P43/00;C07K14/47;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12Q1/68;(IPC1-7):A61K48/00 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|